Afro Middle East Asian symposium on cancer cooperation

Abstract

This manuscript captures the discussion and recommendations that came out of a special Afro Asian symposium involving 13 countries. Unmet needs and cost-effective solutions with special emphasis on training form the backbone of practical next steps.

Oncology status in five SAARC countries: A critical appraisal of 2012 versus 2014 statistics

“…After carefully reading the article by Parikh et al ., we found that Table 2 (insight into oncology status of various countries) of his article[1] shows a close resemblance to Table 4 (insight into oncology status of SAARC countries) of the article by Noronha et al . [2] At first instance, the tables seemed to be similar with the difference in the number of countries for which the data was provided.…”

“…We read with great interest the articles entitled “Afro Middle East Asian symposium on cancer cooperation.”[1] We commend the organizing committee of Afro-Asian symposium, 2014, for their scrupulous efforts of arranging a conference on such a large scale where dignitaries from 16 different countries met on the common ground with a unanimous motive of improving the oncology status in their respective countries and globally, on a wider perspective. We also take the opportunity to applaud Parikh et al .…”

“…The statistical data for five SAARC countries that are Bhutan, Pakistan, India, Bangladesh, and Nepal, was presented in both the tables, but one contained the data for 2012[2] and another for 2014. [1] From the statistical comparison between the past and the present data, we could get a fair idea regarding the progression/regression of oncology status in these countries over the period of nearly 1½ years.…”

Is pancreaticodoudenectomy with vascular resection a safe procedure in developing country? Early outcomes and review of national literature

“…The post-op mortality was high (10% or more) in these studies compared to recent standards. It is surprising that a country with a [27,28].…”

"Welcome to the China Special Issues of IJC"

“…[10] Our ultimate objective is to contribute to overall benefit for the patients suffering from cancer. [11] …”